Pak–US experts advance plan for integrated Centre of Excellence
IV Report
KARACHI: The idea to build the country’s first
collaborative Centre of Excellence spanning neuroscience, oncology, genomics
and other advanced specialties received a major push at a two-day international
symposium hosted at Salim Habib University and later at Governor House Karachi.
The event, attended by leading Pakistani and international physicians and
researchers, highlighted emerging opportunities for advanced clinical care,
research and training, according to a press release.
Leaders from the Indus Hospital & Health
Network (IHHN) and Insight Hospital & Medical Center, Chicago, worked
together at the inaugural IndusInsight2025 Symposium to design a coordinated
roadmap for integrated and high-end medical services in Pakistan. The moot
concluded on December 7 (Sunday).
IHHN Founder and President Dr Abdul Bari Khan
underscored that equitable access must remain central to the initiative. “This
collaboration is not merely an academic partnership—it is a promise to the
people of Pakistan. Advanced neuroscience, oncology and genomic services must
not remain privileges for the few,” he remarked.
Renowned neurologist and CEO of Novel
Therapeutics, Dr Teepu Siddique, highlighted the potential of establishing
Pakistan’s first dedicated Genetics Institute. He said a robust genetics
platform would pave the way for early diagnosis, personalised treatments and
research breakthroughs that could strengthen national healthcare.
Speaking on system-wide strengthening, IHHN’s
Executive Director Medical Services, Dr Muhammad Shamvil Ashraf, emphasised
embedding evidence-based protocols into routine practice. “If Pakistan is to
compete globally, we must build systems where quality assurance, research
integration and standardised protocols anchor every level of care,” he
observed.
For pediatric oncology, Senior Consultant Dr
Syed Ahmer Hamid called for deeper global collaboration to uplift childhood
cancer services. “Children in Pakistan deserve the same advanced cancer
treatments available anywhere in the world. Through this partnership, we aim to
bring cutting-edge therapies directly to where they are needed most,” he said.
Concluding the symposium, Acting CEO of IHHN,
Dr Amin Chinoy, announced plans to establish a joint working group to structure
the proposed Centre of Excellence and Genetics Institute. The group will work
on identifying funding avenues and initiating long-term programmes such as
virtual tumor boards, research collaborations and capacity-building exchanges.

Comments
Post a Comment